CClinicalTrials.gg
Status unknownNCT03791996Updated Oct 17, 2019

Cranioplasty Cognitive Outcome Study

An interventional study of "Early" cranioplasty in Cognitive Impairment and Brain Herniation, sponsored by Kwong Wah Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 79 Years. Per ClinicalTrials.gov, last updated 2019-10-17.

Sponsored by Kwong Wah Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
All
01

Study summary

This will be a multicenter prospective randomized study of adult patients with an acquired skull defect as a result of craniectomy and considered suitable for cranioplasty, i.e. reconstruction of the skull defect, at all seven Hong Kong Hospital Authority neurosurgical units. Patients that underwent their primary craniectomy operation at any of the Hospital Authority neurosurgery centers from the 1st March 2019 and considered suitable for cranioplasty will be included in this study. Those who underwent their primary craniectomy before 1st March 2019 or at an institution other than the aforementioned neurosurgical units will be excluded. Data from clinical records, operation notes, medication-dispensing records, laboratory records and radiological reports will be collected.

30 adult patients with craniectomy will be recruited and randomized into two groups: "early" cranioplasty, i.e. performed within 3 months of craniectomy, and "late", i.e. cranioplasty performed more than 3 months after the operation. The aim of the study is to determine whether early cranioplasty can improve on patient's cognitive performance compared to those who undergo the procedure after 3 months.

Read the detailed description

Decompressive craniectomy, a neurosurgical procedure where a portion of the skull calvarium is removed, is a life-saving procedure. The complication rate of cranioplasty, a neurosurgical procedure where the acquired skull defect is reconstructed, ranges from 11% to 26% and includes postoperative hemorrhage and infection. (4) The syndrome of the trephined is a recognized long-term complication in which certain groups of patients, experience debilitating neurocognitive deficits in addition to chronic headache, dizziness, fatigability and clinical depression. (2) It is believed that the lack of an overlying bone may cause undue significant atmospheric pressure on the underlying cortex, thereby reducing cerebral perfusion and cerebrospinal fluid flow. There are reports that cognitive improvement can be observed in up to 30% of patients after cranioplasty yet the underlying mechanism for this observation is unclear. (1) Some studies have demonstrated enhanced cerebral perfusion by non-invasive investigations, but there is a lack of large scale systematically performed studies to verify such cerebral hemodynamic effects. (1-3) Clinical equipoise exists regarding the optimum timing of cranioplasty procedures after craniectomies. While the anecdotal practice of delaying cranioplasty for at least 3 months after a craniectomy is common, local and overseas observational studies suggest that performing early cranioplasties (i.e. within 3 months) is equally safe in terms of infection and other operative complications. (4-6)

02

Conditions studied

  • Cognitive Impairment
  • Brain Herniation

Keywords

  • Cranioplasty
  • Craniectomy
  • Cognitive impairment
  • Syndrome of the trephined
03

In context

Cognitive Dysfunction

3,845 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 30 is below the median of 64 across 2,810 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Kwong Wah Hospital is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age greater than or equal to 18 years-old,
  2. Craniectomy was performed due to head injury, infarct or spontaneous intracerebral hemorrhage, and benign tumors.
  3. Craniectomy skull defect size of >10cm at its longest diameter
  4. Craniectomy performed at any of the Hospital Authority's Neurosurgical Centers after 1st March 2019

Exclusion criteria

Exclusion Criteria:

  1. Age older than 80 years-old,
  2. Patients cannot communicate by obeying simple command,
  3. Patients who are unfit for cranioplasty as decided by the treating neurosurgeon
  4. Posterior fossa craniectomy
  5. Craniectomy performed before 1st March 2019
  6. Craniectomy performed at an institution outside the Hospital Authority
  7. Any pre-existing illness that renders the patient moderately or severely disabled before the brain insult.
  8. Patients that need an additional procedure e.g. cerebrospinal fluid shunting with cranioplasty in the same setting.
  9. History of central nervous system infection
  10. Craniectomy-related complications such as hemorrhage or surgical site infection requiring surgical intervention or deemed to affect patient's long-term cognitive outcome
  11. Claustrophobia or any other medical condition that prohibits the patient from undergo MRI scanning
  12. Patients who cannot understand spoken English or Chinese
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • No intervention
    "Late" cranioplasty

    Subjects undergoing cranioplasty within 3 months after craniectomy.

  • Experimental
    "Early" cranioplasty

    Subjects undergoing cranioplasty beyond 3 months after craniectomy.

    Procedure: "Early" cranioplasty

Interventions

  • Procedure"Early" cranioplasty

    Subjects undergoing cranioplasty beyond 3 months after craniectomy.

06

What researchers measure

Primary outcomes

  1. Montreal Cognitive Assessment (MOCA)

    Minimum (worse): 0/30; Maximum (best) 30/30. Higher values represent a better outcome.

    Time frame: 3-months

  2. Neurobehavioural Cognitive State Examination (NCSE)

    Multi-domain assessment involving: orientation, attention, registration, comprehension, repetition, naming, construction, calculation, similarities,judgement. Stratification of each domain into mild, moderate and severe impairment. The higher the number the better the outcome.

    Time frame: 3-months

  3. Rivermead Behavioural Memory Test (RBMT)

    Time frame: 3-months

Secondary outcomes

  1. Motor assessment

    Medical Research Council limb power

    Time frame: 3-months

  2. Modified Functional Ambulation Category (MFAC)

    7 ordinal scale assessment. The lower the scale, the worse the ambulatory ability of the patient. I: bed bound; 2: wheel-chair bound; 3: dependent walker; 4: Assisted walker; 5: Supervised walker; 6: Indoor walker; 7: Outdoor walker (patient can walk anywhere).

    Time frame: 3-months

  3. Quality of life assessment

    Short Form-36 (SF-36)

    Time frame: 3-months

  4. Psychological assessment

    Beck depression inventory (BDI)

    Time frame: 3-months

  5. Caregiver assessment

    Caregiver Strain Index

    Time frame: 3-months

  6. Caregiver

    Caregiver self-assessment questionnaire

    Time frame: 3-months

  7. MRI cerebral perfusion assessment

    Cerebral blood flow

    Time frame: 3-months

07

Study locations

1 of 1 sites recruiting
  • Kwong Wah Hospital
    Hong Kong, Hong Kong, China
    • Peter YM Woo, FRCS (SN) · Contact · peterymwoo@gmail.com · 852+ 3517 2275
    • Peter YM Woo, FRCS (SN) · Principal investigator
    Recruiting
08

References and documents

Publications

  • Halani SH, Chu JK, Malcolm JG, Rindler RS, Allen JW, Grossberg JA, Pradilla G, Ahmad FU. Effects of Cranioplasty on Cerebral Blood Flow Following Decompressive Craniectomy: A Systematic Review of the Literature. Neurosurgery. 2017 Aug 1;81(2):204-216. doi: 10.1093/neuros/nyx054. PubMed 28368505 ↗
  • Bender A, Heulin S, Rohrer S, Mehrkens JH, Heidecke V, Straube A, Pfefferkorn T. Early cranioplasty may improve outcome in neurological patients with decompressive craniectomy. Brain Inj. 2013;27(9):1073-9. doi: 10.3109/02699052.2013.794972. Epub 2013 May 10. PubMed 23662672 ↗
  • Ashayeri K, M Jackson E, Huang J, Brem H, Gordon CR. Syndrome of the Trephined: A Systematic Review. Neurosurgery. 2016 Oct;79(4):525-34. doi: 10.1227/NEU.0000000000001366. PubMed 27489166 ↗
  • Malcolm JG, Rindler RS, Chu JK, Grossberg JA, Pradilla G, Ahmad FU. Complications following cranioplasty and relationship to timing: A systematic review and meta-analysis. J Clin Neurosci. 2016 Nov;33:39-51. doi: 10.1016/j.jocn.2016.04.017. Epub 2016 Aug 4. PubMed 27499122 ↗
  • Xu H, Niu C, Fu X, Ding W, Ling S, Jiang X, Ji Y. Early cranioplasty vs. late cranioplasty for the treatment of cranial defect: A systematic review. Clin Neurol Neurosurg. 2015 Sep;136:33-40. doi: 10.1016/j.clineuro.2015.05.031. Epub 2015 May 29. PubMed 26056810 ↗
  • Tsang AC, Hui VK, Lui WM, Leung GK. Complications of post-craniectomy cranioplasty: risk factor analysis and implications for treatment planning. J Clin Neurosci. 2015 May;22(5):834-7. doi: 10.1016/j.jocn.2014.11.021. Epub 2015 Mar 28. PubMed 25827865 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03791996
Lead sponsor
Kwong Wah Hospital
Collaborators
The Queen Elizabeth Hospital, Queen Mary Hospital, Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, Princess Margaret Hospital, Canada, Tuen Mun Hospital, Pamela Youde Nethersole Eastern Hospital
Responsible party
Peter Woo Yat Ming (Principal Investigator, Kwong Wah Hospital) — Principal investigator
First posted
Jan 3, 2019
Start date
Mar 1, 2019
Primary completion
Sep 1, 2020 (estimated)
Completion
Mar 1, 2021 (estimated)
Last update
Oct 17, 2019

Study contacts

Calvin Mak, MBBS FRCS
Contact
mhk349@ha.org.hk
35066026
Marina Lee
Contact
leeymm@ha.org.hk
35066026
Calvin Mak, MBBS FRCS
principal investigator · Neurosurgery, Queen Elizabeth Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion